Protecting Early Investors in Capital-Intensive Life Science Companies

Angel investors often invest at the seed stage of a company's development. The typically smaller round sizes and lower valuations allow early individual investors to gain a meaningful stake in a given company. However,...

Behind the Curtain | Single Family Offices and ESG Investing with Brian Cork

Brian Patrick Cork is a principal of brian cork COACHING™, which provides client services in business design, strategy development, executive team-building, and financial capital formation. Please tell us a little about...

VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC adds two life science leaders, bringing additional key insight to the team. VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively...

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

Atkins will bring critical insight into the development and commercialization of inhaled medicines Albuquerque, NM - Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been...

The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World

As discussed in my previous article “Portfolio Diversification During Times of Market Volatility,”[1] one of the few positive outcomes of the worldwide pandemic is the increasing recognition of the power of innovation...

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC Adds Acclaimed Life Science Veteran to Their Team. Fayetteville, AR - VIC Technology Venture Development announced today the appointment of Fenel M. Eloi, a seasoned executive in the life science sector, to their...

Inside CU Innovations: An Interview with Executive Director, Kim Muller

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. We recently had a chance to...

From the Corner Office: Solenic Medical Reaches a Two-Year Anniversary Milestone

The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. Solenic Medical’s second year was unlike...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that it has been awarded a National Institutes of Health (NIH) Small Business Innovation Research (SBIR)...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
White Paper
Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Nicole Shirkey-Son, PhD
From The Corner Office
From the Corner Office with Enhance Diagnostics